Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) Gross Margin (2023 - 2025)

Bioharvest Sciences has reported Gross Margin over the past 3 years, most recently at 57.63% for Q4 2025.

  • For Q4 2025, Gross Margin rose 98.0% year-over-year to 57.63%; the TTM value through Dec 2025 reached 59.34%, up 399.0%, while the annual FY2025 figure was 59.34%, 399.0% up from the prior year.
  • Gross Margin was 57.63% for Q4 2025 at Bioharvest Sciences, down from 61.43% in the prior quarter.
  • Across five years, Gross Margin topped out at 61.43% in Q3 2025 and bottomed at 40.22% in Q2 2023.
  • The 3-year median for Gross Margin is 56.65% (2024), against an average of 53.98%.
  • Year-over-year, Gross Margin soared 1228bps in 2024 and then soared 98bps in 2025.
  • Over 3 years, Gross Margin stood at 50.73% in 2023, then rose by 12bps to 56.65% in 2024, then rose by 2bps to 57.63% in 2025.
  • The last three reported values for Gross Margin were 57.63% (Q4 2025), 61.43% (Q3 2025), and 59.73% (Q2 2025) per Business Quant data.